Driehaus Capital Management LLC acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 900,000 shares of the company’s stock, valued at approximately $9,112,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in OACCU. Schonfeld Strategic Advisors LLC acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the fourth quarter valued at $8,518,000. ADAR1 Capital Management LLC acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 4th quarter valued at about $5,065,000. Ghisallo Capital Management LLC purchased a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth approximately $4,558,000. Affinity Asset Advisors LLC acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the fourth quarter worth approximately $2,538,000. Finally, Whitebox Advisors LLC purchased a new position in Oaktree Acquisition Corp. III Life Sciences during the fourth quarter valued at approximately $2,532,000.
Oaktree Acquisition Corp. III Life Sciences Price Performance
OACCU stock opened at $10.54 on Friday. The business has a 50 day moving average of $10.35. Oaktree Acquisition Corp. III Life Sciences has a 12-month low of $9.99 and a 12-month high of $10.60.
Oaktree Acquisition Corp. III Life Sciences Company Profile
We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.
Featured Articles
- Five stocks we like better than Oaktree Acquisition Corp. III Life Sciences
- Using the MarketBeat Stock Split Calculator
- Google Is Betting Big on Nuclear Reactors—Should You?
- Golden Cross Stocks: Pattern, Examples and Charts
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- How to Invest in Insurance Companies: A GuideÂ
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Want to see what other hedge funds are holding OACCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU – Free Report).
Receive News & Ratings for Oaktree Acquisition Corp. III Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
